| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 190 | 2024 | 2893 | 10.040 |
Why?
|
| Particulate Matter | 187 | 2024 | 2602 | 8.980 |
Why?
|
| Air Pollution | 131 | 2024 | 2355 | 8.320 |
Why?
|
| Environmental Exposure | 145 | 2024 | 4483 | 6.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 60 | 2024 | 2518 | 3.990 |
Why?
|
| Maternal Exposure | 49 | 2024 | 1067 | 3.980 |
Why?
|
| Environmental Monitoring | 70 | 2021 | 1460 | 3.810 |
Why?
|
| Environmental Pollutants | 24 | 2024 | 1277 | 3.220 |
Why?
|
| Soot | 30 | 2024 | 221 | 2.970 |
Why?
|
| Vehicle Emissions | 39 | 2019 | 655 | 2.940 |
Why?
|
| Air Pollution, Indoor | 31 | 2024 | 900 | 2.540 |
Why?
|
| Bayes Theorem | 45 | 2024 | 2326 | 2.530 |
Why?
|
| Inhalation Exposure | 24 | 2020 | 432 | 2.180 |
Why?
|
| Models, Statistical | 38 | 2023 | 5073 | 2.100 |
Why?
|
| Asthma | 35 | 2024 | 6233 | 1.580 |
Why?
|
| Respiratory Tract Diseases | 9 | 2019 | 750 | 1.580 |
Why?
|
| Birth Weight | 24 | 2023 | 2101 | 1.420 |
Why?
|
| Biostatistics | 4 | 2020 | 163 | 1.350 |
Why?
|
| Biometry | 12 | 2016 | 561 | 1.320 |
Why?
|
| Pregnancy | 123 | 2024 | 29868 | 1.310 |
Why?
|
| DNA Methylation | 28 | 2023 | 4391 | 1.300 |
Why?
|
| Aircraft | 3 | 2019 | 130 | 1.300 |
Why?
|
| Radon | 7 | 2024 | 87 | 1.300 |
Why?
|
| Particle Size | 51 | 2023 | 1648 | 1.290 |
Why?
|
| Temperature | 18 | 2024 | 2223 | 1.230 |
Why?
|
| Censuses | 7 | 2023 | 198 | 1.210 |
Why?
|
| Linear Models | 41 | 2021 | 5866 | 1.200 |
Why?
|
| Respiratory Sounds | 10 | 2022 | 702 | 1.190 |
Why?
|
| Metals | 10 | 2023 | 719 | 1.180 |
Why?
|
| Manganese | 12 | 2023 | 393 | 1.160 |
Why?
|
| Radioactivity | 6 | 2023 | 59 | 1.110 |
Why?
|
| Occupational Diseases | 5 | 2018 | 1490 | 1.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 18 | 2024 | 3204 | 1.070 |
Why?
|
| Boston | 68 | 2024 | 9313 | 1.060 |
Why?
|
| Carbon | 17 | 2016 | 665 | 1.050 |
Why?
|
| Fluorocarbons | 9 | 2023 | 492 | 1.000 |
Why?
|
| Nitrogen Dioxide | 19 | 2024 | 522 | 0.960 |
Why?
|
| Residence Characteristics | 20 | 2024 | 2090 | 0.920 |
Why?
|
| Seasons | 31 | 2024 | 1518 | 0.910 |
Why?
|
| Data Interpretation, Statistical | 16 | 2017 | 2689 | 0.910 |
Why?
|
| Regression Analysis | 17 | 2018 | 6338 | 0.900 |
Why?
|
| Air Pollutants, Radioactive | 6 | 2024 | 52 | 0.900 |
Why?
|
| Humans | 448 | 2024 | 760617 | 0.880 |
Why?
|
| Arsenic | 8 | 2022 | 362 | 0.870 |
Why?
|
| Mortality | 19 | 2022 | 2899 | 0.820 |
Why?
|
| Aerospace Medicine | 3 | 2018 | 95 | 0.810 |
Why?
|
| Power Plants | 6 | 2011 | 124 | 0.800 |
Why?
|
| Female | 284 | 2024 | 392148 | 0.790 |
Why?
|
| Urban Population | 21 | 2023 | 2033 | 0.780 |
Why?
|
| Male | 276 | 2024 | 360358 | 0.730 |
Why?
|
| Massachusetts | 44 | 2024 | 8833 | 0.730 |
Why?
|
| Hydrocortisone | 8 | 2022 | 1819 | 0.710 |
Why?
|
| Aging | 32 | 2024 | 8699 | 0.700 |
Why?
|
| Oxidative Stress | 20 | 2023 | 3113 | 0.700 |
Why?
|
| Aerosols | 13 | 2018 | 635 | 0.700 |
Why?
|
| Housing | 13 | 2023 | 669 | 0.690 |
Why?
|
| Child Development | 10 | 2020 | 2300 | 0.680 |
Why?
|
| Humidity | 5 | 2024 | 205 | 0.680 |
Why?
|
| Lead | 10 | 2021 | 879 | 0.670 |
Why?
|
| Population Groups | 1 | 2020 | 207 | 0.670 |
Why?
|
| Socioeconomic Factors | 19 | 2024 | 7798 | 0.670 |
Why?
|
| Environmental Health | 4 | 2018 | 288 | 0.640 |
Why?
|
| Computer Simulation | 22 | 2023 | 6233 | 0.640 |
Why?
|
| Homicide | 4 | 2017 | 294 | 0.630 |
Why?
|
| Heart Rate | 19 | 2024 | 4180 | 0.620 |
Why?
|
| Mexico | 16 | 2024 | 756 | 0.610 |
Why?
|
| Ozone | 14 | 2024 | 483 | 0.610 |
Why?
|
| Aviation | 1 | 2018 | 49 | 0.600 |
Why?
|
| Schools | 8 | 2021 | 1483 | 0.600 |
Why?
|
| Hydrocarbons, Chlorinated | 4 | 2023 | 121 | 0.590 |
Why?
|
| Alkanesulfonic Acids | 6 | 2023 | 201 | 0.590 |
Why?
|
| Health Surveys | 9 | 2019 | 4037 | 0.590 |
Why?
|
| Blood Pressure | 17 | 2020 | 8472 | 0.580 |
Why?
|
| DNA, Mitochondrial | 7 | 2021 | 865 | 0.580 |
Why?
|
| Health Status Disparities | 7 | 2020 | 1846 | 0.570 |
Why?
|
| Clothing | 1 | 2018 | 96 | 0.570 |
Why?
|
| Pregnancy Outcome | 6 | 2024 | 2921 | 0.570 |
Why?
|
| Cohort Studies | 69 | 2024 | 41457 | 0.550 |
Why?
|
| Longitudinal Studies | 33 | 2021 | 14591 | 0.550 |
Why?
|
| United States | 83 | 2024 | 72272 | 0.540 |
Why?
|
| Infant, Newborn | 50 | 2024 | 26180 | 0.540 |
Why?
|
| Aged | 139 | 2024 | 169042 | 0.530 |
Why?
|
| Epigenesis, Genetic | 12 | 2024 | 3794 | 0.530 |
Why?
|
| Poverty | 7 | 2024 | 2692 | 0.530 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 819 | 0.520 |
Why?
|
| Polychlorinated Biphenyls | 3 | 2023 | 236 | 0.520 |
Why?
|
| Flame Retardants | 3 | 2021 | 96 | 0.520 |
Why?
|
| Cardiovascular Diseases | 20 | 2024 | 15498 | 0.520 |
Why?
|
| Stress, Psychological | 13 | 2024 | 4488 | 0.510 |
Why?
|
| Hypersensitivity | 5 | 2019 | 1167 | 0.510 |
Why?
|
| Vital Capacity | 8 | 2020 | 971 | 0.510 |
Why?
|
| Infant Mortality | 3 | 2015 | 751 | 0.510 |
Why?
|
| Phthalic Acids | 5 | 2024 | 478 | 0.510 |
Why?
|
| Occupational Exposure | 5 | 2019 | 1813 | 0.500 |
Why?
|
| Arrhythmias, Cardiac | 10 | 2024 | 2234 | 0.500 |
Why?
|
| Child | 80 | 2024 | 80079 | 0.490 |
Why?
|
| Solar Activity | 4 | 2024 | 44 | 0.490 |
Why?
|
| Airway Obstruction | 1 | 2020 | 661 | 0.480 |
Why?
|
| Fetal Development | 7 | 2023 | 769 | 0.470 |
Why?
|
| Prospective Studies | 61 | 2024 | 54360 | 0.470 |
Why?
|
| Selection Bias | 1 | 2016 | 359 | 0.470 |
Why?
|
| Endocrine Disruptors | 3 | 2024 | 264 | 0.460 |
Why?
|
| Inflammation | 20 | 2024 | 10760 | 0.460 |
Why?
|
| Models, Theoretical | 18 | 2019 | 3567 | 0.460 |
Why?
|
| Forced Expiratory Volume | 9 | 2020 | 1814 | 0.460 |
Why?
|
| Epidemiology | 2 | 2018 | 279 | 0.450 |
Why?
|
| Cognition | 15 | 2024 | 6987 | 0.450 |
Why?
|
| Violence | 3 | 2017 | 936 | 0.440 |
Why?
|
| Human Rights Abuses | 1 | 2013 | 31 | 0.440 |
Why?
|
| Abortion, Legal | 1 | 2015 | 113 | 0.440 |
Why?
|
| Dibutyl Phthalate | 3 | 2018 | 29 | 0.440 |
Why?
|
| Adult | 125 | 2024 | 220969 | 0.430 |
Why?
|
| Lung | 17 | 2022 | 9998 | 0.430 |
Why?
|
| Young Adult | 64 | 2024 | 59179 | 0.420 |
Why?
|
| Causality | 3 | 2021 | 1240 | 0.420 |
Why?
|
| Infant | 41 | 2024 | 36152 | 0.420 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 3351 | 0.410 |
Why?
|
| Urban Health | 8 | 2020 | 532 | 0.410 |
Why?
|
| Veterans | 8 | 2022 | 2649 | 0.400 |
Why?
|
| Middle Aged | 113 | 2024 | 220584 | 0.400 |
Why?
|
| Sulfates | 9 | 2017 | 379 | 0.400 |
Why?
|
| Environment | 4 | 2019 | 1123 | 0.390 |
Why?
|
| Cities | 11 | 2020 | 546 | 0.390 |
Why?
|
| Adolescent | 68 | 2024 | 88234 | 0.390 |
Why?
|
| Social Justice | 2 | 2024 | 478 | 0.390 |
Why?
|
| Population Dynamics | 1 | 2013 | 306 | 0.380 |
Why?
|
| Autonomic Nervous System | 4 | 2019 | 704 | 0.380 |
Why?
|
| Menarche | 2 | 2024 | 532 | 0.380 |
Why?
|
| Body Mass Index | 11 | 2024 | 12943 | 0.370 |
Why?
|
| Hazardous Substances | 3 | 2017 | 153 | 0.370 |
Why?
|
| Epigenomics | 4 | 2024 | 942 | 0.360 |
Why?
|
| Aged, 80 and over | 67 | 2024 | 58894 | 0.360 |
Why?
|
| Remote Sensing Technology | 4 | 2017 | 92 | 0.350 |
Why?
|
| Premature Birth | 6 | 2024 | 1782 | 0.350 |
Why?
|
| Child, Preschool | 43 | 2024 | 42188 | 0.340 |
Why?
|
| Temperament | 3 | 2024 | 297 | 0.340 |
Why?
|
| Hot Temperature | 5 | 2023 | 1437 | 0.340 |
Why?
|
| Privacy | 2 | 2023 | 233 | 0.340 |
Why?
|
| Gamma Rays | 3 | 2020 | 318 | 0.340 |
Why?
|
| Depression | 13 | 2023 | 8132 | 0.340 |
Why?
|
| Toxicity Tests | 6 | 2011 | 114 | 0.340 |
Why?
|
| Phenytoin | 6 | 2005 | 190 | 0.340 |
Why?
|
| Dust | 9 | 2024 | 487 | 0.330 |
Why?
|
| Infant, Low Birth Weight | 4 | 2019 | 869 | 0.330 |
Why?
|
| Hair | 5 | 2020 | 498 | 0.330 |
Why?
|
| Coal | 7 | 2023 | 122 | 0.330 |
Why?
|
| Carbon Monoxide | 8 | 2019 | 547 | 0.330 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6925 | 0.330 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2021 | 461 | 0.320 |
Why?
|
| Oxidants, Photochemical | 3 | 2017 | 76 | 0.320 |
Why?
|
| Skin Diseases | 1 | 2018 | 1094 | 0.320 |
Why?
|
| Spacecraft | 4 | 2017 | 28 | 0.320 |
Why?
|
| United States Environmental Protection Agency | 8 | 2020 | 139 | 0.320 |
Why?
|
| Cross-Over Studies | 12 | 2019 | 2079 | 0.310 |
Why?
|
| Metals, Heavy | 2 | 2016 | 148 | 0.310 |
Why?
|
| Endothelium | 3 | 2020 | 764 | 0.310 |
Why?
|
| Hypertension | 10 | 2020 | 8529 | 0.310 |
Why?
|
| Nutrition Surveys | 6 | 2023 | 1723 | 0.310 |
Why?
|
| New England | 8 | 2023 | 1051 | 0.310 |
Why?
|
| Nails | 6 | 2022 | 296 | 0.310 |
Why?
|
| Food Supply | 2 | 2024 | 539 | 0.310 |
Why?
|
| Family Characteristics | 5 | 2023 | 992 | 0.310 |
Why?
|
| Endotoxins | 3 | 2015 | 520 | 0.300 |
Why?
|
| Menstrual Cycle | 4 | 2024 | 539 | 0.300 |
Why?
|
| Live Birth | 2 | 2023 | 510 | 0.300 |
Why?
|
| Mercury | 3 | 2022 | 290 | 0.300 |
Why?
|
| Epidemiologic Studies | 4 | 2023 | 673 | 0.300 |
Why?
|
| Gestational Age | 12 | 2023 | 3577 | 0.300 |
Why?
|
| Hospitalization | 8 | 2024 | 10704 | 0.290 |
Why?
|
| Abnormalities, Drug-Induced | 7 | 2005 | 339 | 0.290 |
Why?
|
| Phenols | 2 | 2024 | 516 | 0.290 |
Why?
|
| Sex Factors | 20 | 2021 | 10548 | 0.290 |
Why?
|
| Income | 5 | 2015 | 1870 | 0.280 |
Why?
|
| Radiation Monitoring | 3 | 2023 | 103 | 0.280 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2358 | 0.270 |
Why?
|
| Dogs | 10 | 2017 | 3838 | 0.270 |
Why?
|
| Geologic Sediments | 2 | 2004 | 80 | 0.270 |
Why?
|
| Automobiles | 2 | 2018 | 111 | 0.270 |
Why?
|
| Cause of Death | 5 | 2020 | 3683 | 0.270 |
Why?
|
| Fetal Blood | 7 | 2019 | 1347 | 0.270 |
Why?
|
| Noise, Transportation | 2 | 2018 | 56 | 0.270 |
Why?
|
| Bone Density | 4 | 2020 | 3548 | 0.260 |
Why?
|
| Police | 2 | 2019 | 157 | 0.260 |
Why?
|
| Cough | 2 | 2024 | 595 | 0.260 |
Why?
|
| Vitamin B Complex | 2 | 2019 | 299 | 0.260 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 26049 | 0.260 |
Why?
|
| Infertility, Female | 2 | 2024 | 760 | 0.260 |
Why?
|
| Epidemiologic Methods | 3 | 2008 | 1335 | 0.260 |
Why?
|
| Prenatal Care | 1 | 2013 | 1140 | 0.250 |
Why?
|
| Decanoic Acids | 3 | 2021 | 68 | 0.250 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2016 | 1128 | 0.250 |
Why?
|
| Respiratory Function Tests | 11 | 2020 | 1683 | 0.240 |
Why?
|
| Cluster Analysis | 7 | 2020 | 2700 | 0.240 |
Why?
|
| Obesity | 9 | 2024 | 12933 | 0.240 |
Why?
|
| Fertilization in Vitro | 3 | 2019 | 1292 | 0.240 |
Why?
|
| Folic Acid | 4 | 2023 | 1323 | 0.240 |
Why?
|
| Prevalence | 10 | 2019 | 15689 | 0.240 |
Why?
|
| Fibrinogen | 5 | 2017 | 887 | 0.240 |
Why?
|
| Smoke | 3 | 2016 | 235 | 0.240 |
Why?
|
| Mass Media | 2 | 2017 | 302 | 0.240 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2019 | 294 | 0.240 |
Why?
|
| Disease Susceptibility | 3 | 2010 | 1788 | 0.240 |
Why?
|
| Risk Factors | 41 | 2024 | 74115 | 0.240 |
Why?
|
| Population Surveillance | 3 | 2014 | 2595 | 0.230 |
Why?
|
| Incidence | 14 | 2024 | 21337 | 0.230 |
Why?
|
| Bangladesh | 5 | 2019 | 732 | 0.230 |
Why?
|
| Benzophenones | 1 | 2024 | 57 | 0.230 |
Why?
|
| Cooking | 6 | 2016 | 308 | 0.230 |
Why?
|
| Ventricular Premature Complexes | 3 | 2023 | 108 | 0.230 |
Why?
|
| Myocardial Ischemia | 6 | 2024 | 2110 | 0.230 |
Why?
|
| Telomere | 4 | 2023 | 940 | 0.220 |
Why?
|
| Saliva | 4 | 2019 | 828 | 0.220 |
Why?
|
| Time Factors | 28 | 2024 | 39913 | 0.220 |
Why?
|
| Logistic Models | 13 | 2021 | 13245 | 0.210 |
Why?
|
| Heart | 6 | 2019 | 4403 | 0.210 |
Why?
|
| Copper | 2 | 2023 | 367 | 0.210 |
Why?
|
| Adipokines | 2 | 2017 | 308 | 0.210 |
Why?
|
| Water Pollutants, Chemical | 4 | 2017 | 359 | 0.210 |
Why?
|
| Anticonvulsants | 5 | 2005 | 1906 | 0.210 |
Why?
|
| Weather | 5 | 2019 | 231 | 0.210 |
Why?
|
| Leukocytes | 4 | 2022 | 2023 | 0.210 |
Why?
|
| Myocardial Infarction | 14 | 2022 | 11459 | 0.210 |
Why?
|
| Executive Function | 3 | 2022 | 1391 | 0.210 |
Why?
|
| Stroke | 11 | 2023 | 9712 | 0.210 |
Why?
|
| Caprylates | 2 | 2021 | 115 | 0.200 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 580 | 0.200 |
Why?
|
| Nickel | 2 | 2020 | 128 | 0.200 |
Why?
|
| Tooth | 2 | 2021 | 210 | 0.200 |
Why?
|
| Arsenicals | 2 | 2019 | 118 | 0.200 |
Why?
|
| Pregnancy Complications | 5 | 2020 | 2948 | 0.200 |
Why?
|
| Mumps | 1 | 2023 | 71 | 0.200 |
Why?
|
| Mesalamine | 3 | 2018 | 135 | 0.200 |
Why?
|
| Radiation Injuries | 2 | 2020 | 1189 | 0.200 |
Why?
|
| Social Class | 6 | 2016 | 1992 | 0.200 |
Why?
|
| Leukocyte Count | 2 | 2020 | 1597 | 0.200 |
Why?
|
| Malus | 1 | 2022 | 49 | 0.200 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.200 |
Why?
|
| Beta Particles | 2 | 2020 | 51 | 0.190 |
Why?
|
| Facial Bones | 1 | 2003 | 208 | 0.190 |
Why?
|
| Seawater | 3 | 2016 | 124 | 0.190 |
Why?
|
| Women's Health | 6 | 2023 | 2065 | 0.190 |
Why?
|
| Nitrates | 2 | 2017 | 263 | 0.190 |
Why?
|
| Sulfur | 2 | 2017 | 161 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 5 | 2024 | 1474 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10199 | 0.190 |
Why?
|
| Parabens | 2 | 2024 | 114 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2020 | 2270 | 0.190 |
Why?
|
| Nurses | 2 | 2023 | 2477 | 0.190 |
Why?
|
| Italy | 5 | 2023 | 842 | 0.190 |
Why?
|
| Satellite Communications | 3 | 2015 | 13 | 0.190 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2022 | 701 | 0.190 |
Why?
|
| Pollen | 1 | 2001 | 80 | 0.190 |
Why?
|
| Aging, Premature | 1 | 2021 | 44 | 0.190 |
Why?
|
| Pregnancy Trimesters | 2 | 2023 | 197 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 691 | 0.180 |
Why?
|
| Lymphocyte Count | 2 | 2020 | 778 | 0.180 |
Why?
|
| Allergens | 4 | 2021 | 1429 | 0.180 |
Why?
|
| Tooth, Deciduous | 2 | 2018 | 76 | 0.180 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2018 | 99 | 0.180 |
Why?
|
| Interleukin-6 | 7 | 2024 | 3206 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2574 | 0.180 |
Why?
|
| Electrocardiography, Ambulatory | 6 | 2009 | 574 | 0.180 |
Why?
|
| United States Department of Veterans Affairs | 6 | 2017 | 928 | 0.170 |
Why?
|
| Intelligence | 3 | 2020 | 923 | 0.170 |
Why?
|
| Glutathione Transferase | 4 | 2019 | 565 | 0.170 |
Why?
|
| Likelihood Functions | 5 | 2011 | 991 | 0.170 |
Why?
|
| Paternal Exposure | 1 | 2020 | 96 | 0.170 |
Why?
|
| Pesticides | 1 | 2022 | 296 | 0.170 |
Why?
|
| Sample Size | 3 | 2023 | 838 | 0.170 |
Why?
|
| Hemodynamics | 3 | 2015 | 4160 | 0.170 |
Why?
|
| Selenium | 1 | 2022 | 417 | 0.170 |
Why?
|
| Mining | 2 | 2017 | 93 | 0.170 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2024 | 376 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2021 | 6390 | 0.170 |
Why?
|
| ROC Curve | 3 | 2003 | 3575 | 0.160 |
Why?
|
| Quinolinic Acid | 1 | 2019 | 67 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 582 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2024 | 636 | 0.160 |
Why?
|
| Odds Ratio | 12 | 2021 | 9643 | 0.160 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 234 | 0.160 |
Why?
|
| Meconium | 1 | 2019 | 47 | 0.160 |
Why?
|
| Plant Proteins | 1 | 2001 | 369 | 0.160 |
Why?
|
| Rats | 18 | 2019 | 23717 | 0.160 |
Why?
|
| Postmenopause | 2 | 2019 | 2511 | 0.160 |
Why?
|
| Models, Biological | 6 | 2012 | 9461 | 0.160 |
Why?
|
| Age Factors | 17 | 2024 | 18381 | 0.160 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 532 | 0.160 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 258 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2017 | 8166 | 0.160 |
Why?
|
| Parturition | 2 | 2023 | 447 | 0.150 |
Why?
|
| Climate | 1 | 2019 | 147 | 0.150 |
Why?
|
| Alloys | 1 | 2018 | 110 | 0.150 |
Why?
|
| Risk | 11 | 2019 | 9604 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2018 | 462 | 0.150 |
Why?
|
| Skull | 1 | 2003 | 818 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12142 | 0.150 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 1250 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2023 | 3954 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 1754 | 0.150 |
Why?
|
| Geography | 3 | 2015 | 652 | 0.150 |
Why?
|
| Body Composition | 2 | 2018 | 2426 | 0.150 |
Why?
|
| Baroreflex | 2 | 2017 | 149 | 0.150 |
Why?
|
| Alaska | 1 | 2018 | 70 | 0.150 |
Why?
|
| Dentin | 1 | 2018 | 75 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 349 | 0.150 |
Why?
|
| Calibration | 6 | 2022 | 817 | 0.150 |
Why?
|
| Wood | 2 | 2015 | 92 | 0.150 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 30 | 0.150 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2019 | 496 | 0.150 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2017 | 69 | 0.150 |
Why?
|
| Confidence Intervals | 4 | 2019 | 2925 | 0.150 |
Why?
|
| Plasticizers | 1 | 2017 | 52 | 0.150 |
Why?
|
| Neutrophils | 5 | 2020 | 3763 | 0.150 |
Why?
|
| Pest Control | 1 | 2017 | 29 | 0.140 |
Why?
|
| Endocrine Glands | 1 | 2017 | 101 | 0.140 |
Why?
|
| Hypospadias | 1 | 2018 | 97 | 0.140 |
Why?
|
| Ecosystem | 1 | 2021 | 487 | 0.140 |
Why?
|
| Cryptorchidism | 1 | 2018 | 151 | 0.140 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 524 | 0.140 |
Why?
|
| Child Behavior | 2 | 2020 | 848 | 0.140 |
Why?
|
| Iron | 2 | 2023 | 1790 | 0.140 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 66 | 0.140 |
Why?
|
| Patient Admission | 2 | 2015 | 1365 | 0.140 |
Why?
|
| Fungi | 2 | 2022 | 338 | 0.140 |
Why?
|
| Binomial Distribution | 1 | 1996 | 23 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 161 | 0.140 |
Why?
|
| Pre-Eclampsia | 2 | 2024 | 1230 | 0.140 |
Why?
|
| Death Certificates | 1 | 2017 | 167 | 0.140 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 981 | 0.140 |
Why?
|
| Halogenated Diphenyl Ethers | 3 | 2021 | 82 | 0.140 |
Why?
|
| C-Reactive Protein | 9 | 2024 | 3822 | 0.140 |
Why?
|
| Phenobarbital | 5 | 2005 | 191 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2005 | 2218 | 0.130 |
Why?
|
| Herbicides | 1 | 2017 | 105 | 0.130 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.130 |
Why?
|
| Environment Design | 1 | 2018 | 173 | 0.130 |
Why?
|
| Cosmetics | 1 | 2017 | 102 | 0.130 |
Why?
|
| Animals | 39 | 2022 | 168201 | 0.130 |
Why?
|
| Law Enforcement | 1 | 2017 | 112 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 138 | 0.130 |
Why?
|
| Los Angeles | 3 | 2011 | 244 | 0.130 |
Why?
|
| Nitrogen Oxides | 4 | 2017 | 129 | 0.130 |
Why?
|
| Cold Temperature | 2 | 2017 | 784 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 403 | 0.130 |
Why?
|
| Insecticides | 1 | 2017 | 191 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.130 |
Why?
|
| Meningomyelocele | 1 | 2017 | 171 | 0.130 |
Why?
|
| Smoking | 5 | 2019 | 9050 | 0.130 |
Why?
|
| Developing Countries | 2 | 2018 | 2867 | 0.130 |
Why?
|
| Rural Health | 1 | 2017 | 296 | 0.130 |
Why?
|
| Postpartum Period | 2 | 2022 | 1178 | 0.120 |
Why?
|
| Language Development | 1 | 2016 | 183 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 808 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 544 | 0.120 |
Why?
|
| Sperm Motility | 1 | 2016 | 266 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2020 | 667 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2024 | 517 | 0.120 |
Why?
|
| Brugada Syndrome | 1 | 2016 | 91 | 0.120 |
Why?
|
| Georgia | 2 | 2013 | 184 | 0.120 |
Why?
|
| Nasal Mucosa | 1 | 2018 | 415 | 0.120 |
Why?
|
| Polychaeta | 2 | 2004 | 5 | 0.120 |
Why?
|
| Fingers | 5 | 2005 | 506 | 0.120 |
Why?
|
| Optical Phenomena | 1 | 2015 | 106 | 0.120 |
Why?
|
| Acetaminophen | 1 | 2019 | 555 | 0.120 |
Why?
|
| Minority Health | 1 | 2015 | 79 | 0.120 |
Why?
|
| Pregnant Women | 2 | 2018 | 567 | 0.120 |
Why?
|
| Respiration | 2 | 2011 | 1656 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2015 | 123 | 0.120 |
Why?
|
| Diet, Reducing | 1 | 2018 | 485 | 0.120 |
Why?
|
| Immunoglobulin E | 4 | 2018 | 1502 | 0.120 |
Why?
|
| Normal Distribution | 1 | 2014 | 272 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2024 | 1228 | 0.110 |
Why?
|
| Nervous System | 1 | 2017 | 545 | 0.110 |
Why?
|
| Proportional Hazards Models | 10 | 2020 | 12447 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 2726 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 39063 | 0.110 |
Why?
|
| Psychotic Disorders | 2 | 2022 | 3220 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 898 | 0.110 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 575 | 0.110 |
Why?
|
| Semen | 1 | 2016 | 347 | 0.110 |
Why?
|
| Radon Daughters | 2 | 2023 | 11 | 0.110 |
Why?
|
| School Health Services | 1 | 2017 | 384 | 0.110 |
Why?
|
| Coronary Artery Disease | 5 | 2016 | 6403 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2022 | 3805 | 0.110 |
Why?
|
| Erectile Dysfunction | 1 | 2017 | 444 | 0.110 |
Why?
|
| Coronary Circulation | 2 | 2010 | 1569 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 393 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2020 | 3431 | 0.110 |
Why?
|
| Educational Status | 3 | 2018 | 2509 | 0.110 |
Why?
|
| Neoplasms | 3 | 2020 | 22131 | 0.110 |
Why?
|
| Life Change Events | 2 | 2015 | 952 | 0.110 |
Why?
|
| Firearms | 2 | 2017 | 626 | 0.110 |
Why?
|
| Parasympathetic Nervous System | 1 | 2013 | 143 | 0.110 |
Why?
|
| Cockroaches | 2 | 2017 | 97 | 0.100 |
Why?
|
| Peroxidase | 1 | 2016 | 610 | 0.100 |
Why?
|
| Rural Population | 4 | 2021 | 2276 | 0.100 |
Why?
|
| Colombia | 1 | 2013 | 282 | 0.100 |
Why?
|
| Climate Change | 1 | 2019 | 500 | 0.100 |
Why?
|
| Stress, Physiological | 2 | 2017 | 1403 | 0.100 |
Why?
|
| Data Collection | 3 | 2021 | 3315 | 0.100 |
Why?
|
| Toes | 2 | 2005 | 209 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2018 | 2637 | 0.100 |
Why?
|
| Civil Rights | 1 | 2013 | 132 | 0.100 |
Why?
|
| SEER Program | 2 | 2015 | 1450 | 0.100 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1884 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2014 | 366 | 0.100 |
Why?
|
| Placenta | 2 | 2023 | 1709 | 0.100 |
Why?
|
| Longevity | 1 | 2019 | 1064 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 1948 | 0.100 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 755 | 0.100 |
Why?
|
| Self Report | 3 | 2019 | 3723 | 0.100 |
Why?
|
| Retroelements | 1 | 2013 | 162 | 0.100 |
Why?
|
| Transition Elements | 1 | 2011 | 15 | 0.100 |
Why?
|
| Medicare | 8 | 2024 | 6765 | 0.100 |
Why?
|
| Adiposity | 2 | 2019 | 1879 | 0.100 |
Why?
|
| Alkanes | 1 | 2011 | 41 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 1390 | 0.090 |
Why?
|
| Brain Ischemia | 3 | 2013 | 3028 | 0.090 |
Why?
|
| Silicones | 2 | 2022 | 228 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2017 | 787 | 0.090 |
Why?
|
| State Health Plans | 1 | 2013 | 219 | 0.090 |
Why?
|
| Software | 2 | 2018 | 4431 | 0.090 |
Why?
|
| Macrophages, Alveolar | 2 | 2006 | 411 | 0.090 |
Why?
|
| Mothers | 5 | 2018 | 2194 | 0.090 |
Why?
|
| Verbal Learning | 2 | 2023 | 463 | 0.090 |
Why?
|
| Probability | 3 | 2023 | 2475 | 0.090 |
Why?
|
| Fatigue | 1 | 2018 | 1550 | 0.090 |
Why?
|
| Stachybotrys | 1 | 2010 | 1 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6224 | 0.090 |
Why?
|
| Maximal Midexpiratory Flow Rate | 2 | 2020 | 76 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 519 | 0.090 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 12661 | 0.090 |
Why?
|
| Wechsler Scales | 2 | 2021 | 257 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2018 | 3548 | 0.090 |
Why?
|
| Southeastern United States | 3 | 2015 | 91 | 0.090 |
Why?
|
| Students | 2 | 2017 | 1733 | 0.090 |
Why?
|
| Congenital Abnormalities | 2 | 2014 | 709 | 0.090 |
Why?
|
| Propensity Score | 2 | 2021 | 1911 | 0.090 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1575 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2018 | 22148 | 0.090 |
Why?
|
| Mycotoxins | 1 | 2010 | 35 | 0.090 |
Why?
|
| Risk Assessment | 12 | 2020 | 23972 | 0.090 |
Why?
|
| Methylmercury Compounds | 1 | 2011 | 103 | 0.090 |
Why?
|
| Lectins | 1 | 2012 | 489 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5780 | 0.090 |
Why?
|
| Alabama | 2 | 2024 | 108 | 0.090 |
Why?
|
| Sulfur Dioxide | 3 | 2019 | 178 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1242 | 0.080 |
Why?
|
| Databases, Factual | 5 | 2017 | 7960 | 0.080 |
Why?
|
| Exercise | 3 | 2023 | 5886 | 0.080 |
Why?
|
| Vasodilation | 1 | 2014 | 962 | 0.080 |
Why?
|
| Pilot Projects | 6 | 2019 | 8618 | 0.080 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 103 | 0.080 |
Why?
|
| Electrocardiography | 8 | 2017 | 6346 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2013 | 663 | 0.080 |
Why?
|
| Eligibility Determination | 1 | 2013 | 421 | 0.080 |
Why?
|
| Aorta | 1 | 2017 | 2041 | 0.080 |
Why?
|
| Visual Perception | 1 | 2017 | 1388 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2016 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2015 | 1047 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 368 | 0.080 |
Why?
|
| Uncertainty | 1 | 2014 | 752 | 0.080 |
Why?
|
| Hypotension, Orthostatic | 1 | 2012 | 258 | 0.080 |
Why?
|
| Fatty Acids | 3 | 2022 | 1808 | 0.080 |
Why?
|
| California | 2 | 2018 | 1430 | 0.080 |
Why?
|
| Catalase | 3 | 2016 | 218 | 0.080 |
Why?
|
| Cell Count | 2 | 2011 | 1835 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 473 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2015 | 1197 | 0.080 |
Why?
|
| Bronchitis | 3 | 2014 | 196 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3619 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1662 | 0.080 |
Why?
|
| Calcinosis | 1 | 2017 | 1469 | 0.080 |
Why?
|
| Athletic Injuries | 1 | 2018 | 1216 | 0.080 |
Why?
|
| Oxygen | 2 | 2014 | 4226 | 0.080 |
Why?
|
| Ventricular Function | 1 | 2010 | 406 | 0.080 |
Why?
|
| Glucose | 2 | 2017 | 4345 | 0.070 |
Why?
|
| Population Density | 2 | 2018 | 193 | 0.070 |
Why?
|
| Cadmium | 2 | 2022 | 214 | 0.070 |
Why?
|
| Motor Vehicles | 1 | 2009 | 282 | 0.070 |
Why?
|
| Microspheres | 2 | 2008 | 782 | 0.070 |
Why?
|
| Independent Living | 1 | 2012 | 577 | 0.070 |
Why?
|
| Heart Failure | 3 | 2024 | 11669 | 0.070 |
Why?
|
| Insect Control | 1 | 2007 | 29 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 491 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2012 | 4341 | 0.070 |
Why?
|
| Postural Balance | 1 | 2012 | 622 | 0.070 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2007 | 221 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1403 | 0.070 |
Why?
|
| DNA Damage | 1 | 2017 | 2446 | 0.070 |
Why?
|
| Sex | 2 | 2017 | 53 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4803 | 0.070 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 20074 | 0.070 |
Why?
|
| Overweight | 1 | 2018 | 2417 | 0.070 |
Why?
|
| Reaction Time | 1 | 2013 | 2087 | 0.070 |
Why?
|
| Histones | 1 | 2017 | 2577 | 0.070 |
Why?
|
| Myocardium | 5 | 2011 | 4724 | 0.070 |
Why?
|
| Multivariate Analysis | 5 | 2019 | 12043 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 619 | 0.070 |
Why?
|
| Methylation | 2 | 2019 | 1077 | 0.070 |
Why?
|
| Ectromelia | 1 | 2006 | 28 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 1348 | 0.070 |
Why?
|
| Attention | 2 | 2015 | 2396 | 0.070 |
Why?
|
| Weight Loss | 1 | 2018 | 2682 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2007 | 189 | 0.070 |
Why?
|
| Leptin | 1 | 2014 | 1595 | 0.070 |
Why?
|
| Public Housing | 1 | 2007 | 140 | 0.060 |
Why?
|
| Patella | 3 | 2016 | 315 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 20988 | 0.060 |
Why?
|
| Heart Diseases | 5 | 2014 | 2778 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1509 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 2 | 2022 | 552 | 0.060 |
Why?
|
| Glutamate-Cysteine Ligase | 2 | 2016 | 23 | 0.060 |
Why?
|
| Teratogens | 2 | 2003 | 117 | 0.060 |
Why?
|
| Lung Diseases | 3 | 2007 | 1909 | 0.060 |
Why?
|
| Spirometry | 2 | 2022 | 928 | 0.060 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 56 | 0.060 |
Why?
|
| Vitamin D | 1 | 2019 | 3302 | 0.060 |
Why?
|
| Macrophages | 2 | 2011 | 5758 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 878 | 0.060 |
Why?
|
| Memory, Short-Term | 2 | 2022 | 982 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1303 | 0.060 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 144 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 219 | 0.060 |
Why?
|
| Poverty Areas | 1 | 2006 | 263 | 0.060 |
Why?
|
| Rain | 2 | 2003 | 60 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4433 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 908 | 0.060 |
Why?
|
| Bronchitis, Chronic | 2 | 2002 | 82 | 0.060 |
Why?
|
| Nutritional Status | 2 | 2018 | 1596 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 426 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2491 | 0.060 |
Why?
|
| Tibia | 3 | 2016 | 1069 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2017 | 6561 | 0.060 |
Why?
|
| Carbanilides | 1 | 2024 | 18 | 0.060 |
Why?
|
| HIV Infections | 3 | 2020 | 17337 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2350 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2020 | 633 | 0.060 |
Why?
|
| Ghana | 2 | 2017 | 315 | 0.060 |
Why?
|
| Biomass | 2 | 2015 | 127 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2135 | 0.060 |
Why?
|
| Algorithms | 5 | 2019 | 14018 | 0.060 |
Why?
|
| Automobile Driving | 1 | 2009 | 441 | 0.060 |
Why?
|
| Quality Control | 2 | 2005 | 831 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2019 | 2604 | 0.060 |
Why?
|
| Midwestern United States | 1 | 2023 | 70 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2009 | 992 | 0.060 |
Why?
|
| Mid-Atlantic Region | 2 | 2014 | 24 | 0.060 |
Why?
|
| Face | 3 | 2005 | 1026 | 0.060 |
Why?
|
| Space-Time Clustering | 2 | 2016 | 45 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2006 | 851 | 0.050 |
Why?
|
| Age Determination by Teeth | 1 | 2003 | 10 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2011 | 834 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 12719 | 0.050 |
Why?
|
| Bone and Bones | 2 | 2011 | 2565 | 0.050 |
Why?
|
| Hexachlorobenzene | 1 | 2023 | 27 | 0.050 |
Why?
|
| Complex Mixtures | 1 | 2022 | 29 | 0.050 |
Why?
|
| Ethmoid Bone | 1 | 2003 | 35 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2400 | 0.050 |
Why?
|
| Androgens | 2 | 2022 | 1285 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2007 | 1161 | 0.050 |
Why?
|
| Tooth Abnormalities | 1 | 2003 | 56 | 0.050 |
Why?
|
| Menstruation Disturbances | 1 | 2024 | 143 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 274 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 2 | 2016 | 366 | 0.050 |
Why?
|
| Radiography, Panoramic | 1 | 2003 | 118 | 0.050 |
Why?
|
| Dermatoglyphics | 1 | 2002 | 20 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 86 | 0.050 |
Why?
|
| Swimming | 1 | 2003 | 208 | 0.050 |
Why?
|
| Age Determination by Skeleton | 1 | 2003 | 126 | 0.050 |
Why?
|
| Enterococcus | 1 | 2003 | 159 | 0.050 |
Why?
|
| Breath Tests | 2 | 2018 | 299 | 0.050 |
Why?
|
| Medicaid | 2 | 2013 | 2814 | 0.050 |
Why?
|
| Memory | 3 | 2017 | 2192 | 0.050 |
Why?
|
| Arteries | 1 | 2007 | 1122 | 0.050 |
Why?
|
| Sick Building Syndrome | 1 | 2021 | 17 | 0.050 |
Why?
|
| CpG Islands | 2 | 2019 | 1192 | 0.050 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18221 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2007 | 524 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 975 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2024 | 726 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13382 | 0.050 |
Why?
|
| Baltimore | 3 | 2007 | 231 | 0.050 |
Why?
|
| Research Design | 5 | 2024 | 6174 | 0.050 |
Why?
|
| Consciousness | 1 | 2007 | 600 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 1700 | 0.050 |
Why?
|
| Tanzania | 2 | 2016 | 1390 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2020 | 1217 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2017 | 2278 | 0.050 |
Why?
|
| Fertilization | 1 | 2022 | 198 | 0.050 |
Why?
|
| Cephalometry | 1 | 2003 | 382 | 0.050 |
Why?
|
| Social Environment | 2 | 2017 | 1020 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2013 | 517 | 0.050 |
Why?
|
| Drug Combinations | 2 | 2006 | 2048 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11116 | 0.050 |
Why?
|
| Antioxidants | 3 | 2020 | 1668 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2019 | 15908 | 0.040 |
Why?
|
| Michigan | 1 | 2001 | 339 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2021 | 368 | 0.040 |
Why?
|
| Ethylene Glycol | 1 | 2000 | 31 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2018 | 7050 | 0.040 |
Why?
|
| Pliability | 1 | 2019 | 59 | 0.040 |
Why?
|
| Ferritins | 1 | 2023 | 597 | 0.040 |
Why?
|
| Skull Base | 1 | 2003 | 292 | 0.040 |
Why?
|
| Ohio | 2 | 2014 | 322 | 0.040 |
Why?
|
| Chromium | 1 | 2020 | 132 | 0.040 |
Why?
|
| Anxiety | 3 | 2023 | 4570 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2137 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2002 | 592 | 0.040 |
Why?
|
| Problem Solving | 1 | 2022 | 444 | 0.040 |
Why?
|
| Glioma | 2 | 2012 | 3453 | 0.040 |
Why?
|
| Hospitals | 2 | 2024 | 3877 | 0.040 |
Why?
|
| Maxilla | 1 | 2003 | 494 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2019 | 119 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 211 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2015 | 6634 | 0.040 |
Why?
|
| Lagomorpha | 1 | 1999 | 7 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 245 | 0.040 |
Why?
|
| Emergency Service, Hospital | 3 | 2014 | 7871 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2019 | 18 | 0.040 |
Why?
|
| Luciferases | 1 | 2021 | 712 | 0.040 |
Why?
|
| Fertility | 1 | 2024 | 769 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2020 | 615 | 0.040 |
Why?
|
| Hospitals, Community | 3 | 1986 | 365 | 0.040 |
Why?
|
| Trace Elements | 1 | 2020 | 195 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 47 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 1982 | 287 | 0.040 |
Why?
|
| Pneumonia | 2 | 2002 | 2143 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 3194 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1723 | 0.040 |
Why?
|
| Vitamins | 2 | 2023 | 1635 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1079 | 0.040 |
Why?
|
| Canada | 2 | 2019 | 2118 | 0.040 |
Why?
|
| Illinois | 1 | 2018 | 120 | 0.040 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2018 | 54 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16571 | 0.040 |
Why?
|
| Geographic Information Systems | 2 | 2013 | 281 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 1178 | 0.040 |
Why?
|
| Mandible | 1 | 2003 | 753 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2018 | 145 | 0.040 |
Why?
|
| India | 2 | 2015 | 2286 | 0.040 |
Why?
|
| Vital Statistics | 1 | 2017 | 31 | 0.040 |
Why?
|
| Air Conditioning | 1 | 2017 | 54 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4575 | 0.040 |
Why?
|
| Rest | 2 | 2018 | 918 | 0.040 |
Why?
|
| New Hampshire | 1 | 2017 | 175 | 0.040 |
Why?
|
| Forecasting | 2 | 2019 | 2924 | 0.040 |
Why?
|
| Exercise Test | 1 | 2005 | 2127 | 0.040 |
Why?
|
| Brain | 2 | 2015 | 27101 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2668 | 0.040 |
Why?
|
| Mites | 1 | 2017 | 46 | 0.040 |
Why?
|
| Eosinophils | 1 | 2022 | 953 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 1496 | 0.030 |
Why?
|
| Afghanistan | 1 | 2017 | 77 | 0.030 |
Why?
|
| Heating | 1 | 2017 | 104 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2002 | 786 | 0.030 |
Why?
|
| Rhode Island | 1 | 2017 | 351 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 2202 | 0.030 |
Why?
|
| Cyclins | 1 | 2019 | 594 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 858 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 1745 | 0.030 |
Why?
|
| Quality of Life | 3 | 2024 | 13347 | 0.030 |
Why?
|
| Netherlands | 1 | 2021 | 2221 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 327 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14648 | 0.030 |
Why?
|
| Middle East | 1 | 2017 | 231 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 158 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7847 | 0.030 |
Why?
|
| Estrogens | 1 | 2022 | 1521 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2019 | 3411 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2019 | 373 | 0.030 |
Why?
|
| Dyspnea | 1 | 2024 | 1347 | 0.030 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 5835 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 92 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 1422 | 0.030 |
Why?
|
| New Jersey | 1 | 2016 | 295 | 0.030 |
Why?
|
| Israel | 1 | 2018 | 716 | 0.030 |
Why?
|
| Sperm Count | 1 | 2016 | 229 | 0.030 |
Why?
|
| Monte Carlo Method | 2 | 2012 | 1257 | 0.030 |
Why?
|
| Cats | 1 | 2017 | 975 | 0.030 |
Why?
|
| Urbanization | 1 | 2016 | 100 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2012 | 9026 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5430 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 344 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 29600 | 0.030 |
Why?
|
| Wavelet Analysis | 1 | 2015 | 55 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 256 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 1996 | 355 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1420 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 2018 | 512 | 0.030 |
Why?
|
| Skin Tests | 1 | 2017 | 637 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 994 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 807 | 0.030 |
Why?
|
| Maternal Age | 1 | 2018 | 809 | 0.030 |
Why?
|
| Veterans Health | 1 | 2016 | 215 | 0.030 |
Why?
|
| Time | 1 | 2016 | 545 | 0.030 |
Why?
|
| Pipecolic Acids | 1 | 1995 | 77 | 0.030 |
Why?
|
| Oral Health | 1 | 2020 | 492 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 763 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1982 | 1033 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 957 | 0.030 |
Why?
|
| North Carolina | 4 | 2007 | 322 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2016 | 236 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 436 | 0.030 |
Why?
|
| Sleep | 1 | 2010 | 4758 | 0.030 |
Why?
|
| Gambia | 1 | 2014 | 104 | 0.030 |
Why?
|
| Demography | 1 | 2019 | 1643 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 724 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1927 | 0.030 |
Why?
|
| Vitamin E | 1 | 2018 | 872 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 730 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 824 | 0.030 |
Why?
|
| Indians, North American | 1 | 2017 | 351 | 0.030 |
Why?
|
| Motor Skills | 1 | 2016 | 521 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2023 | 2410 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.030 |
Why?
|
| Mice | 6 | 2022 | 81368 | 0.030 |
Why?
|
| Observer Variation | 2 | 2013 | 2606 | 0.030 |
Why?
|
| Cyprus | 1 | 2013 | 96 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 504 | 0.030 |
Why?
|
| Public Health Administration | 1 | 2015 | 241 | 0.030 |
Why?
|
| China | 1 | 2019 | 2374 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 2423 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 353 | 0.030 |
Why?
|
| Registries | 2 | 2019 | 8207 | 0.030 |
Why?
|
| Intracranial Aneurysm | 1 | 1982 | 1285 | 0.030 |
Why?
|
| Parents | 2 | 2018 | 3563 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2013 | 210 | 0.030 |
Why?
|
| Texas | 1 | 2013 | 403 | 0.030 |
Why?
|
| Life Style | 1 | 2024 | 3904 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 330 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2024 | 80566 | 0.030 |
Why?
|
| Carbamazepine | 2 | 2005 | 224 | 0.030 |
Why?
|
| Base Composition | 1 | 2012 | 290 | 0.020 |
Why?
|
| Comorbidity | 2 | 2017 | 10505 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2015 | 803 | 0.020 |
Why?
|
| Health Services | 1 | 2017 | 751 | 0.020 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 133 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2014 | 286 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 209 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.020 |
Why?
|
| Plethysmography, Whole Body | 1 | 2011 | 25 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 345 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8645 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1370 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2012 | 180 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 582 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2871 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 974 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1810 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 612 | 0.020 |
Why?
|
| Species Specificity | 2 | 2010 | 2411 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
| New York City | 1 | 2013 | 731 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 462 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 143 | 0.020 |
Why?
|
| New York | 4 | 2004 | 874 | 0.020 |
Why?
|
| Genomics | 1 | 2006 | 5822 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2178 | 0.020 |
Why?
|
| Oximetry | 1 | 2014 | 459 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2005 | 3979 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1896 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 650 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1750 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 930 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 2010 | 90 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3302 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2012 | 611 | 0.020 |
Why?
|
| Lipids | 2 | 2016 | 3332 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Child Welfare | 1 | 2014 | 521 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 340 | 0.020 |
Why?
|
| Homocystine | 1 | 1989 | 21 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 894 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1375 | 0.020 |
Why?
|
| Filtration | 1 | 2010 | 228 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 705 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 790 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 697 | 0.020 |
Why?
|
| Epilepsy | 2 | 2002 | 3288 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1971 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1742 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2020 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2000 | 1518 | 0.020 |
Why?
|
| Public Health | 2 | 2015 | 2669 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 965 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 789 | 0.020 |
Why?
|
| San Francisco | 1 | 2008 | 162 | 0.020 |
Why?
|
| Insulin | 1 | 2023 | 6593 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4117 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 2014 | 485 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5463 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2014 | 1565 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2392 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2012 | 10073 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 6188 | 0.020 |
Why?
|
| Floors and Floorcoverings | 1 | 2007 | 27 | 0.020 |
Why?
|
| Weights and Measures | 1 | 2007 | 41 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 901 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3777 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 269 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 554 | 0.020 |
Why?
|
| Sputum | 1 | 2010 | 506 | 0.020 |
Why?
|
| Beds | 1 | 2007 | 47 | 0.020 |
Why?
|
| Telomerase | 1 | 2012 | 744 | 0.020 |
Why?
|
| Body Weight | 1 | 2018 | 4614 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2007 | 194 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2007 | 104 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2008 | 318 | 0.020 |
Why?
|
| Missouri | 1 | 2007 | 115 | 0.020 |
Why?
|
| Small-Area Analysis | 1 | 2006 | 52 | 0.020 |
Why?
|
| Genotype | 2 | 2013 | 12978 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2006 | 104 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3321 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2014 | 781 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4421 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2006 | 154 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2764 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1740 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2481 | 0.020 |
Why?
|
| Homocysteine | 1 | 1989 | 638 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2190 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3735 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 8998 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 699 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1779 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2007 | 311 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2013 | 859 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2006 | 2088 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3145 | 0.020 |
Why?
|
| Ventilation | 1 | 2006 | 128 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2013 | 1768 | 0.020 |
Why?
|
| Transportation | 1 | 2007 | 217 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2231 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2009 | 888 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1989 | 748 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 913 | 0.020 |
Why?
|
| DNA Repair | 1 | 2014 | 2043 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 2896 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 2004 | 63 | 0.010 |
Why?
|
| Alleles | 1 | 2016 | 6861 | 0.010 |
Why?
|
| Rivers | 1 | 2004 | 64 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4470 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 662 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1986 | 448 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1743 | 0.010 |
Why?
|
| Chile | 1 | 2005 | 256 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5491 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4242 | 0.010 |
Why?
|
| Facies | 1 | 2005 | 222 | 0.010 |
Why?
|
| Cytokines | 1 | 2019 | 7373 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2014 | 2107 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 389 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2003 | 154 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2005 | 503 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 470 | 0.010 |
Why?
|
| Mutation | 2 | 2021 | 30016 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2569 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6074 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2003 | 506 | 0.010 |
Why?
|
| Mental Health | 1 | 2018 | 3251 | 0.010 |
Why?
|
| Polysomnography | 1 | 2010 | 1849 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 730 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 328 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10754 | 0.010 |
Why?
|
| Acute Disease | 2 | 2009 | 7237 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2013 | 2881 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 379 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4308 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3800 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5239 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2013 | 12334 | 0.010 |
Why?
|
| Caseins | 1 | 2003 | 104 | 0.010 |
Why?
|
| Polyethylene | 1 | 2004 | 185 | 0.010 |
Why?
|
| Coronary Disease | 2 | 2012 | 5912 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 412 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2661 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2006 | 1056 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1725 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 366 | 0.010 |
Why?
|
| Food | 1 | 2007 | 768 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 1089 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2801 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 360 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12421 | 0.010 |
Why?
|
| Oregon | 3 | 1986 | 147 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2917 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 302 | 0.010 |
Why?
|
| Epiphyses | 1 | 2002 | 190 | 0.010 |
Why?
|
| Spleen | 1 | 2007 | 2286 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2003 | 274 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2003 | 675 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 17878 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1058 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2109 | 0.010 |
Why?
|
| Health Status | 1 | 2014 | 4075 | 0.010 |
Why?
|
| Travel | 1 | 2006 | 796 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 129 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2601 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7568 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3607 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9417 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2261 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15251 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 22115 | 0.010 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1999 | 51 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 652 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8048 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 1156 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2003 | 701 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 1635 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 1241 | 0.010 |
Why?
|
| Valproic Acid | 1 | 2001 | 443 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1999 | 411 | 0.010 |
Why?
|
| Water | 1 | 2004 | 1409 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4919 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 5780 | 0.010 |
Why?
|
| Epitopes | 1 | 2003 | 2501 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2379 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2007 | 3095 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1550 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5812 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1999 | 1526 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 5486 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1376 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1995 | 446 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15828 | 0.010 |
Why?
|
| Coma | 2 | 1986 | 484 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7045 | 0.010 |
Why?
|
| Liver | 1 | 2007 | 7512 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18937 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 5964 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5863 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1995 | 1333 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 4849 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 1540 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1999 | 9311 | 0.000 |
Why?
|
| Cerebral Infarction | 1 | 1986 | 980 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 1 | 1986 | 874 | 0.000 |
Why?
|
| Employment | 1 | 1986 | 1113 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 20556 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1986 | 1315 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1986 | 2417 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 36402 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 2641 | 0.000 |
Why?
|